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Abstract We have developed a rapid and efficient expression 
system to study the human ~2 adrenergic receptor (hn132AR) in 
the fission yeast Schizosaccharomyces pombe. This was achieved 
by cloning the hu~2AR gene, modified by replacement of the 5' 
untranslated and a small part of the N-terminal coding sequence 
(first 14 amino acids) with the corresponding region of the yeast 
Saccharomyces cerevisiae STE2 (a-factor receptor) gene. The 
gene was then placed under the control of a S. pombe constitutive 
promoter for alcohol dehydrogenase (adh). HnI~2AR expression 
was assessed by immunoblot analysis of the chimeric protein with 
an anti-STE2 serum raised against a dodecapeptide homologous 
to the N-terminal amino acids of STE2 and ligand binding was 
assayed using [125I]cyanopindolol. We demonstrate here that the 
chimeric receptor expressed in S. pombe xhibits the same char- 
acteristic ligand specificity and affinity as that of the authentic 
hu~2AR. This system constitutes a convenient alternative to ex- 
isting methods for studying seven transmembrane domain recep- 
tors due to its simplicity and high reproducibility. 
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[5]. The human fl2AR gene was also expressed in E. coli [6,19] 
and in S. cerevisiae [7]. The hufl2AR expressed in E. coli retains 
its pharmacological profile and is capable of coupling to a G 
protein in an in vitro reconstitution system [8]. 
King et al. have programmed S. cerevisiae to express the 
hufl2AR gene. They have shown that the yeast's intrinsic sig- 
nalling pathway could be activated in a fl-adrenergic-agonist- 
dependent manner in cells expressing the human protein. This 
suggests evolutionary similarities may facilitate the expression 
of membrane bound protein in yeast. However, their expression 
technique is laborious and requires everal manipulations in- 
cluding coexpression of the LAC9 gene, a transcriptional 
transactivator p otein, and induction with galactose at late 
exponential phase of cell growth [9]. 
In this paper we report the expression of the huflzAR gene 
in the fission yeast Schizosaccharomyces pombe. We show that 
this organism is a more efficient host than S. cerevisiae and a 
convenient tool to explore expression and binding capacity of 
this class of human receptors. 
2. Materials and methods 
I. Introduction 
Eukaryotic ells can sense a wide variety of external stimuli 
and respond to them through conformational changes of 
plasma membrane r ceptors following specific ligand binding, 
which in turn influences the activity of downstream effector 
molecules. 
The mammalian fl adrenergic receptors (,BAR) are probably 
the most intensively studied cell surface receptors of the nerv- 
ous system. They are members of a class of ligand binding 
receptors containing seven transmembrane domains that cause 
activation of adenylate cyclase. These receptors catalyze the 
binding of GTP to a regulatory protein, Gs, on the inner face 
of the plasma membrane, thereby activating it. Gs then stimu- 
lates adenylate cyclase to produce cAMP [1]. 
The yeast S. cerevisiae also contains imilar 7-span mem- 
brane receptors [2,3], STE2 (c~ factor receptor) and the STE3 
(a factor receptor) proteins. Their transducing pathways, in- 
duced by pheromone binding (c~ or a factor), involves a G 
protein [2,3]. In fact, the expression of a mammalian Gs~ sub- 
unit in mutant yeast lacking the corresponding endogenous 
protein (encoded by GPA1) restores viability [4]. 
Most of the fl adrenergic receptors, identified by gene cloning 
and sequence analysis, have been expressed in eukaryotic cells 
*Corresponding author. Fax: (39) (6) 9067 3323. 
2.1. Strains and Media 
E. coli K514 (hsrk, hsmk derivative of strains C600) was used [10]. 
Schizosaccharomyces pombe (S. pombe) leul-32,h- strain was grown in 
either ich medium (YEA) or synthetic minimal medium [11]. 
2.2. Plasmid construction 
Two different expression vectors containing the huflzAR gene were 
constructed, pEVP11, an S. pombe expression vector that contains a
polylinker region under the control of the S. pombe constitutive pro- 
moter for alcohol dehydrogenase (adh) (Fig. 1A) was used in each case. 
For one construct, pEVflAR (Fig. 1 B) the whole cDNA hufl2AR gene 
(gift from Dr. Lefkowitz) was removed from the eukaryotic vector 
pkSV10 [12] by SacI BamHI digestion and placed irectly into a simi- 
larly digested region of the pEVP11 polylinker region. 
The other construct replaces the N-terminal region of the hufl2AR 
gene with the N-terminal region from the S. cerevisiae STE2 gene [2]. 
Briefly, a synthetic oligonucleotide (Fig. 2A) was made corresponding 
to 11 bp of noncoding and 42 bp of coding sequence from the STE2 
gene. This sequence was cloned into the BamHI and AatII sites of the 
plasmid YIP5 [13]. The resulting plasmid, YIP5-oligo, was then di- 
gested with SspI and AatlI to open it up and a AatII SalI fragment 
isolated from the huflzAR-pkSV10 clone was ligated into this plasmid, 
filling in the mismatched SalI SspI sites. The recombinant plasmid 
yi-STE2fl2 is shown in Fig. 2B. A BamHI-BamHI fragment was then 
isolated from the yi-STE2~2 plasmid and inserted into the BamHI site 
of the polylinker region of the expression vector pEVPI 1 resulting in 
pEVSTE2flAR (Fig. 1B). 
2.3. Fractionation of yeast membranes 
For the isolation of the inner and outer membranes, yeast cells were 
grown in EMM medium with 40 pM alprenolol to an OD600 value of 
2. Then the cells were harvested by centrifugation at 6,000 × g and the 
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pellet was resuspended in 5 ml of SCE buffer (1 M Sorbitol, 0.1 M 
sodium citrate, 60 mM EDTA, pH 7.0) with the addition of 1% fl- 
mercaptoethanol and 0.05 mg/ml Zymolase 100T (Kirin, Japan). After 
1 h of incubation at 37°C, spheroblasts were harvested by centrifuga- 
tiou at 3,500 x g and resuspended in 2 ml lysis buffer (50 mM Tris-HC1 
pH 7.4 5 mM EDTA) with the addition of 1 mM PMSF and 20 12g 
leupeptin. Spheroblasts were lysed at 4°C with glass beads using a 
Brz~un homogenizer (Braun Melsungen, Germany). After removing the 
gla:~s beads the suspension was centrifuged at85,000 x g for 30 min. The 
pelet was resuspended in 150-200 121 of lysis buffer and the protein 
co~ centration was measured according to Bradford [14]. 
2.4 Binding assays 
! 'ive to ten 12g of yeast membranes were spotted onto nitrocellulose 
flit ~rs (8 cm in diameter, Schleicher and Schuell, Germany) and were 
im abated in 10 ml binding buffer (50 mM Tris-HCl, 150 mM NaC1, 
5 • M EDTA) supplemented with 2% bovine serum albumin (BSA), for 
1 t at room temperature by gentle shaking. Then the filters were incu- 
bated for 90 min. in the same buffer with ~25I-labeled cyanopindolol, 
([~: I]CYP, 2000 Ci/mmol., Amersham, UK) at a final concentration f
20 pM. Filters were washed four times for 15 min each with 10 ml of 
bii~ding buffer supplemented with 0.2% Tween 20, air dried and then 
ext,osed for 12-16 h at -70  °C to X-ray film with an intensifying 
scl :en. The binding assay was also performed in solution at the same 
pr, tein concentration and incubated in 1 ml of binding buffer for 30 
mit at 37°C. Reactions were stopped by filtration on Whatman GF-C 
tilt ~rs followed by one wash with 20 ml of cold buffer. 
3m, x and Kd values were determined by varying [~25I]CYP concentra- 
tions (2-300 pM) in the presence of 10 12M alprenolol. Displacement 
of I25I]CYP (present at a concentration f 20 pM) with various concen- 
tra ions of unlabeled competitors was also measured. 
2.: Immunoblots 
~,n antibody raised against a dodecapeptide constructed from the 
N-erminal sequence of STE2 (a gift from Dr. F. Scavizzi) was used in 
im~uunoblot analysis to detect he chimeric receptor protein produced 
by pEVSTE2flAR transformed cells (Fig. 3). Briefly, membranes from 
lys;d yeast were solubilized in Laemmli's ample buffer containing 10% 
S[I~S and run on a 12% polyacrylamide g l [15]. Proteins were trans- 
fel ed onto a nitrocellulose membrane using a mini trans-blot cell 
(BioRad) in 25 mM Tris-HC1, pH 7.4, 192 mM glycine at 150 mA for 
1 hour [16]. This membrane was then blocked using phosphate-buffered 
saline (PBS) containing 2% BSA and 0.05% Tween 20 for 30 min. A 
1 : 1000 dilution of the rabbit anti-STE2 serum in blocking buffer was 
incubated with the membrane for 1.5 h at room temperature. The 
membrane was then washed three times with the same buffer and 
incubated with a 1 : 1000 dilution of goat anti-rabbit alkaline phosphat- 
ase antibody for 1.5 h. Bands were detected by colorimetric reaction 
after three washes in blocking buffer, a rinse in AP buffer (100 mM 
Tris-HC1, pH 9.5, 100 mM NaCI, 5 mM MgC12) and then a 1 h incuba- 
tion at room temperature in the dark with 10 ml AP buffer containing 
66 121 of NBT (nitroblue tetrazolum) and 33 121 of BCIP (5-bromo-4- 
chloro-3-indonylphosphate). 
3. Resu l ts  
3.1. Plasmid construction 
We chose two cloning strategies directed towards a stable 
expression of the huflzAR gene in S. pombe. In both recombi- 
nant plasmids, the cloned hufl2AR gene was under the control 
of the S. pombe constitutive promoter for alcohol dehydroge- 
nase (adh) in the expression vector pEVP l l  (Fig. 1A). One 
approach used an unmodified hufl2AR cDNA sequence, which 
contained the entire coding sequence followed by 250 bp that 
included the RNA transcription termination signal cloned into 
the S. pombe expression vector pEVP11 (plasmid pEVflAR, 
Fig. 1B). The other used a N-terminally modified hufl2AR gene. 
In this instance, a specific STE2 oligonucleotide s quence (Fig. 
2A) corresponding to the N-terminal region of STE2, replaced 
the 5' untranslated region and the coding sequence for the first 
22 N-terminal amino acids of the hufl2AR gene. This gene was 
then cloned into the S. pombe expression vector (plasmid 
pEVSTE2flAR, Fig. 1B). This procedure is consistent with the 
strategy used to express the hufl2AR gene in the yeast S. cere- 
visiae [7]. The transformed cells were grown in glucose media 
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Fig. 1. Yeast expression vectors. (A) Yeast plasmid pEVP11. (B) The recombinant plasmid pEVSTE2flAR constructed by inserting, at the BamHI 
site of the polylinker, the BamHI BamHI fragment isolated from YISTE2flAR. The recombinant plasmid pEVflAR contains the whole hufl2AR gene 
cloned into the SaeI-BamHI sites of the pEVP11 polylinker. 
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Fig. 2. Construction of yeast p]asmid yI-STE2flAR. (A) A synthetic 
oligonucleotide corresponding to ll bp of noncoding and 42 bp of 
coding sequence from the STE2 gene [6]. (B) The plasmid yI-STE2flAR 
was constructed by inserting ofBamHI AatII fragment containing the 
synthetic oligonucleotide and then by inserting aAatlI SalI fragment 
containing the hufl2AR. 
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Fig. 3. Immunoblots with a rabbit polyclonal antibody against the first 
12 amino acids of the STE2 receptor. (Lane a) Nontransformed cells. 
(Lane b) The control strain containing the plasmid pEVP11. (Lane c) 
S. pombe cells transformed with plasmid pEVSTE2flAR. 
until late exponential phase and the cell membranes were 
screened by immunoblot analysis and ligand binding. 
3.2. Immunoassay 
The expression of the hufl2AR receptor in the yeast S. pombe 
was first detected by immunoblot analysis of extracts from cells 
transformed with pEVP11 and pEVSTE2fl2AR plasmids (Fig. 
3). Total cellular proteins were separated by SDS PAGE and 
then blotted onto nitrocellulose sheets and reacted with a rabbit 
polyclonal antibody against he first 12 aminoacids of the STE2 
receptor present in the chimeric protein STE-fl2AR (Fig. 2A). 
Immune complexes were detected by successive incubation with 
alkaline phosphatase conjugated goat anti-rabbit mmunoglob- 
ulin G (Ig G). 
S. pombe cells that contained the plasmid pEVSTE2flAR 
synthesized two novel polypeptides that are recognized by anti- 
STE2 antibodies (Fig. 3, lane c). The upper band had an elec- 
trophoretic mobility similar to that of the authentic human 
fl2-adrenergic receptor glycoprotein, molecular weight 64 kDa 
[17]. Since the theoretical molecular weight for the nonglycosyl- 
ated full length fl2AR protein is 46 kDa [18], the lower band 
shown in Fig. 3 lane c, might correspond to that protein. 
No such polypeptides were produced in nontransformed cells 
(Fig. 3 lane a) or in the control strain containing the plasmid 
pEVP11 (Fig. 3 lane b). 
3.3. Receptor pharmacology 
To determine the pharmacological profile of the receptor 
encoded by the chimeric hufl2AR gene, yeast transformants 
carrying the vector pEVPll or the pEVSTE2flAR construct 
were examined. Transformants were tested for the presence of 
fl2-adrenergic binding sites by using the antagonist [125I]CYP in 
saturation experiments [6]. 
Crude membranes prepared from cells transformed with 
pEVSTE2flAR showed specific and saturable binding of 
[125I]CYP (Fig. 4) whereas no binding was detected using mem- 
branes from transformants obtained with the vector alone. 
Data analysis indicated a single class of binding sites with a Ka 
of 50/.tM and densities of 7.5 pmol/mg (Fig. 5). 
No appreciable ligand binding could be detected with mem- 
branes from the pEVfl2AR transformants (data not shown). 
This observation could conceivably reflect folding-stability 
and/or processing (e.g. glycosylation) problems of the human 
receptor protein which lacks the S. cerevisiae STE2 N-terminal 
sequence. The affinities of a series of adrenergic ligands in 
competition binding studies with [125I]CYP confirmed the struc- 
tural integrity of the fl2-adrenergic binding sites detected in the 
pEVSTE2flAR transformants. The ligands included two ag- 
onists (isoproterenol and epinephrine) and the antagonist al- 
prenolol. The competition curve are depicted in Fig. 6. 
3.4. Filter assay 
S. pombe membrane preparations were used to determine the 
binding of [125I]CYP to receptor proteins immobilized on nitro- 
cellulose filters. Different concentrations of membrane proteins 
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Fig. 4. [1251]CYP binding to crude membranes prepared from cells 
containing the fusion gene. Results correspond to two independent 
experiments performed intriplicate. Specific binding was defined as the 
amount of total binding (O) minus nonspecific binding measured inthe 
presence of 10 J/M (-)alprenolol (C)). 
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(5.15, 25/.tg) prepared from cells transformed with the pEVpl 1, 
pEVfl2AR and pEVSTE2flAR plasmids were spotted onto ni- 
trocellulose filters. As shown in Fig. 7 there is a strong binding 
signal with pEVSTE2flAR clone and the intensity of the au- 
toradiograph signal appears to be proportional to the amount 
of protein spotted. An unlabeled agonist (alprenolol) competes 
wi~h the radioactive ligand for the binding to the membranes 
(F~g. 7B). Membranes from the cells transformed with pEVpl 1 
de not exhibit any binding activity. Five/lg of pig lung mem- 
brtne proteins, which contain a high concentration of fl2- 
ad "energic receptors, were spotted onto each of the filters to 
pr~wide an internal control (marked with an arrow in Fig. 7) 
[1!]. Contrary to the saturation experiments, in the filter assay, 
m~ mbranes from the cells carrying the pEVflAR plasmid show 
bb ding activity, although weaker than that of the membranes 
fr~ m cells transformed with pEVSTE2flAR. This confirms the 
im 9ortance of the S. cerevisiae STE2 N-terminal sequence to 
ex ~ress the human protein, and shows that the filter assay is 
pr, ,bably a more sensitive method than the ligand binding assay 
pe formed in solution to identify receptor ligand complexes. 
4. Discussion 
['raditionally, most molecular biologists interested in yeast 
ha le directed their attention to one particular species, S. cere- 
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Fig. 7. [125I]CYP binding to different concentrations of membrane pro- 
teins spotted onto nitrocellulose filters, without (A) and with (B) an 
unlabeled competitor (alprenolol). Arrow (a) indicates an internal pos- 
itive control: five ¢zg of pig lung membrane proteins. 
visiae. More recently the powerful genetic and molecular meth- 
ods developed to study this organism have been successfully 
applied to another yeast species, S. pombe. A useful set of 
plasmids has been constructed for cloning in S. pombe [20]. We 
cloned the hufl2AR gene into the plasmid pEVPll [21] under 
the control of the S. pombe adh promoter [22]. The adh gene 
is expressed constitutively in glucose and glycerol/ethanol- 
grown cells; it is estimated that 0.5-2% of the total soluble 
protein is alcohol dehydrogenase. 
S. pombe cells transformed with the recombinant plasmid 
pEVflAR, carrying the complete human receptor coding se- 
quence show poor expression of the hufl2AR protein as demon- 
strated by (1251)CYP binding on filters. This might be due to: 
(i) an inefficient synthesis of the protein in yeast, or (ii) instabil- 
ity of the heterologous protein (possibly due to inefficient mem- 
brane insertion or folding). It has been shown previously that 
the modification of the N-terminal region of a protein alien to 
yeast may improve its expression [23]. King et al. have shown 
that the replacement of the 5' untranslated and part of the 
N-terminal coding sequence of the hufl2AR gene with the corre- 
sponding region of the STE2 (~ factor receptor) gene has im- 
proved the expression of the hufl2AR gene in S. cerevisiae [7] 
We show that the same sequence is functional and necessary 
to express and translocate the foreign protein in S. pombe cells. 
Immunoblot analysis of membrane proteins synthesized in 
transformants carrying the pEVSTE2flAR plasmid revealed a
protein of the same size as the native hufl2AR protein, suggest- 
ing that proper post-translational processing occurred. In addi- 
tion, a smaller protein is produced, consistent with the size of 
the nonglycosylated form. A combination of heterologous gly- 
cosylated and nonglycosylated products has been previously 
observed in yeast [24]. The results reported here confirm that 
the hufl2AR protein is translocated to the membrane of 
S. pombe retaining its ligand binding properties. 
The Kd value reported for the pEVSTE2flAR expression 
system is close to those obtained in mammalian expression 
systems, with values ranging from 21 pM for transfected L-cells 
[25] to 134 pM for the human A 431 cell line [26]. Furthermore, 
the 3 subtype-selective antagonists and agonist compete with 
[125I]CYP binding with a rank order of potency (alpre- 
nolol > isoproterenol >epinephrine) which is consistent with 
published ata [27]. 
Previous papers have reported the use of microbial hosts for 
the expression of neurotransmitter r ceptors [ 19,28,29]. Human 
fl2-adrenergic receptors expressed from fusion genes in E. coli 
and S. cerevisiae retain the 'native' ligand binding profiles 
[6,17,19]. In particular, in the S. cerevisiae cells it was observed 
that maximal expression required several manipulations includ- 
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ing: (i) coexpression of a modified hufl2AR gene and a tran- 
scription transactivator protein (the LAC9 gene product) [9]; 
(ii) growth to late exponential phase; (iii) induction by galactose 
for an additional 36 hours. 
In this report we show that the eukaryote S. pombe is a 
particularly attractive candidate for the expression of mammal- 
ian receptors with 'native' properties ince (i) it is easily manip- 
ulated; (ii) the expression of the receptor gene is constitutive; 
(iii) the protein inserts into the cellular membrane; (iv) it pos- 
sesses a signal transducing machinery with remarkable similar- 
ities to mammalian G protein coupled systems. Recent results 
demonstrate that signals initiated by the mating factors of 
S. pombe are also transmitted through a G protein to the effec- 
tor(s) [29]. 
Most recently Sander et al. have expressed the human D 3 
dopamine receptor in S. cerevisiae and S. pombe [30]. By meas- 
uring the binding of a dopaminergic antagonist (spiperone) to 
membranes prepared from the yeasts they find that recombi- 
nant receptor production is at least 3 times higher in S. pombe 
than in S. cerevisiae. 
Morever the fission yeast utilizes a G protein ~-subunit o 
positively transmit he signal from the mating factor receptor 
to effectors [31]. This resembles the role of G= during signal 
trunsduction i  mammalian cells and therefore makes S. pombe 
a closer model system for investigating mammalian receptor 
function. 
Studies are now in progress to establish functional coupling 
of the recombinant hufl2AR receptor to the G-protein mating 
pathway in S. pombe. 
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